← FDA Drug Approvals (Drugs@FDA)

LATISSE

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2008-12-24

Drug application

FDA Application #

NDA022369

Application type

New Drug Application

Brand name

LATISSE

Generic name

BIMATOPROST

Active ingredients

BIMATOPROST

Dosage form

SOLUTION/DROPS

Route

TOPICAL

Marketing status

Prescription

Sponsor

ABBVIE

Manufacturer

Allergan, Inc.

First approval

2008-12-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown